Fatty Liver Disease-A Multifaceted Disease With Multiple Names? Fatty Liver Disease-A Multifaceted Disease With Multiple Names?
In this commentary, the authors suggest that a more precise terminology for NAFLD is needed, with a more granular view on subcategories of NASH to guide preventive and therapeutic measures.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 7, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

How Diet and Exercise Can Help Manage NAFLD, According to the AGA How Diet and Exercise Can Help Manage NAFLD, According to the AGA
"[W]eight loss is associated with a reduction in liver fat, which provides a potential for reversal of disease progression," wrote Zobair M. Younossi, MD, MPH.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 6, 2021 Category: Internal Medicine Tags: Gastroenterology News Source Type: news

Zydus Cadila receives DCGI nod for NAFLD drug Saroglitazar Mg in India
Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patients who do not consume alcohol or take it in insignificant amounts, but have risk factors such as overweight or obesity, diabetes mellitus (high blood sugar), hypertension (high blood pressure) or dyslipidemia (abnormal blood lipids). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 30, 2020 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q & amp;A podcast: Two ends of the nutrition spectrum in children
Pediatric growth charts track growth in infants, children and adolescents. While children can go through brief periods where they gain or lose a little weight, if children don't gain weight or grow well, they may be diagnosed with failure to thrive. On the other end of the nutrition spectrum are children with non-alcoholic fatty liver [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 4, 2020 Category: Databases & Libraries Source Type: news

NAFLD Prevalence Rising Among Children but Many Undiagnosed NAFLD Prevalence Rising Among Children but Many Undiagnosed
The incidence of nonalcoholic fatty liver disease (NAFLD) is rising among children, but not all youth with obesity are getting recommended screening, a study in California suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2020 Category: Consumer Health News Tags: Pediatrics News Source Type: news

2009 to 2018 Saw Increase in Incidence of NAFLD in Children
THURSDAY, Nov. 19, 2020 -- From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) among children, although many still remain undiagnosed, according to a study published online Nov. 19 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2020 Category: Pharmaceuticals Source Type: news

Lipid Profiles Distinguish Obese and Nonobese NAFLD Patients Lipid Profiles Distinguish Obese and Nonobese NAFLD Patients
Both obese and nonobese individuals can develop nonalcoholic fatty liver disease, and lipid profiles were effective predictors in both groups, based on data from a cross-sectional study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Mayo Clinic Q & amp;A podcast: Cardiometabolic diseases increase COVID-19 risk
An estimated 47 million Americans are living with cardiometabolic diseases, according to the American College of Cardiology. Cardiometabolic diseases are interrelated conditions that include cardiovascular diseases, such as heart disease, stroke, and hypertension, as well as metabolic diseases, such as Type 2 diabetes, obesity and nonalcoholic fatty liver disease. Patients with cardiometabolic diseases have a [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 13, 2020 Category: Databases & Libraries Source Type: news

Eating less suppresses liver cancer due to fatty liver
(Shinshu University) Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan. In order to change this unfortunate state of affairs, it is important to improve the prognosis of non-alcoholic fatty liver disease. Fatty liver is often improved through eating less, getting more exercise, and reducing body weight. The research group posed the question, " Can eating less also suppress liver cancer caused by fatty liver? " (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2020 Category: Cancer & Oncology Source Type: news

Start-up awarded grant to develop contrast agent for early detection of liver disease
(Georgia State University) Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents' Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news

Predictors of Mortality and Disease Progression in NAFLD Predictors of Mortality and Disease Progression in NAFLD
This study aimed to elucidate the factors associated with mortality and disease progression in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a real-world cohort.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NAFLD Closely Tied to Diabetes Risk NAFLD Closely Tied to Diabetes Risk
Patients with non-alcoholic fatty-liver disease (NAFLD) have a higher risk of diabetes, and the more severe the disease the greater the risk, according to new research.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 8, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Newer Antidiabetic Drugs Linked to Improved Liver Enzymes, Steatosis Newer Antidiabetic Drugs Linked to Improved Liver Enzymes, Steatosis
Early evidence suggests that newer diabetes drugs such as pioglitazone may improve liver enzymes and hepatic steatosis and could possibly be useful in treating non-alcoholic fatty liver disease (NAFLD), researchers say.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 6, 2020 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World
How does the criteria for the newly-coined concept"metabolic associated fatty liver disease" differ from those for non-alcoholic fatty liver disease, and what are the real-world implications?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

AI plus CT improves liver steatosis assessment
Artificial intelligence (AI) used with contrast-enhanced abdominal CT makes...Read more on AuntMinnie.comRelated Reading: Can AI screen for nonalcoholic fatty liver disease? Ultrasound useful for evaluating liver steatosis MRI offers view of liver fat loss in obese patients Steatosis complicates MR elastography for liver fibrosis AIUM: Can deep learning classify liver fibrosis on US? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 22, 2020 Category: Radiology Source Type: news

How high fructose intake may trigger fatty liver disease
A study suggested that consuming high amounts of fructose may promote non-alcoholic fatty liver disease by damaging the intestinal barrier. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 14, 2020 Category: Consumer Health News Source Type: news

Researchers find molecular link between liver disease, insulin resistance
Yale researchers have zeroed in on a molecular link between nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 2, 2020 Category: Universities & Medical Training Source Type: news

Menopause may increase risk for non-alcoholic fatty liver disease
Postmenopausal women may be more likely to develop non-alcoholic fatty liver disease due to a reduction in sex hormones, suggests a study published in Endocrinology.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 26, 2020 Category: Endocrinology Source Type: news

New insights into mechanism of therapy to reduce liver fat and prevent fibrosis
(Massachusetts General Hospital) A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 26, 2020 Category: International Medicine & Public Health Source Type: news

TGen review suggests postmenopausal women at risk for nonalcoholic fatty liver disease
(The Translational Genomics Research Institute) NAFLD is the most common cause of liver damage, and can lead to liver cirrhosis and death. It affects nearly 1 in 4 people across the globe. It often is associated with obesity, abnormally high amounts of lipids in the blood, and type 2 diabetes. In the US, the number of NAFLD cases is expected to grow to more than 100 million within the next decade, annually costing an estimated at $292 billion. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2020 Category: International Medicine & Public Health Source Type: news

NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 14, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Fatty liver disease despite a normal weight
(University of Tsukuba) Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index. They found that non-obese NAFLD patients had lower muscle mass and strength (pre-sarcopenia) compared to obese NAFLD patients. Further, fat accumulation in muscles was more common among women. These findings help us understand the clinical presentation of NAFLD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2020 Category: International Medicine & Public Health Source Type: news

NAFLD: It's More Than Just the Fat NAFLD: It's More Than Just the Fat
As a'big club'that everyone could belong to, it's past time to understand NAFLD better.The Curbsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news

Insight on novel genetic approaches to metabolic liver diseases
(Wayne State University - Office of the Vice President for Research) Faculty from Wayne State University's Eugene Applebaum College of Pharmacy and Health Sciences are leading a team of researchers to understand the causal relationships between diabetes, obesity and nonalcoholic fatty liver disease in hopes of developing a treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 31, 2020 Category: International Medicine & Public Health Source Type: news

Women Suffer Less NAFLD but More Advanced Fibrosis Women Suffer Less NAFLD but More Advanced Fibrosis
Given the higher risk of advanced fibrosis among women compared to men with NAFLD, it is plausible that cirrhosis and its complications may occur with greater frequency among women than in men.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 16, 2020 Category: Gastroenterology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Limp handshake? You may be at risk of a potentially fatal liver disease
While social distancing means it's currently barred, new research has revealed that a limp handshake or a weak grip could be an early warning sign of non-alcoholic fatty liver disease. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2020 Category: Consumer Health News Source Type: news

Researchers find promising therapy to fight epidemic of liver disease
(University of Colorado Anschutz Medical Campus) In an effort to combat a growing worldwide epidemic of Nonalcoholic Fatty Liver Disease (NAFLD), scientists have discovered a new target and a new therapy that has shown promising results in preclinical mouse models, according to researchers at the University of Colorado Anschutz Medical Campus. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 8, 2020 Category: Biology Source Type: news

U of SC: How non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation
(University of South Carolina) Research from UofSC associate professor Saurabh Chatterjee's laboratory in Environmental Health Sciences at the Arnold School of Public Health has revealed the cause behind the previously established link between non-alcoholic fatty liver disease and neurological problems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2020 Category: International Medicine & Public Health Source Type: news

Tamoxifen-related NAFLD: Prevalence, Incidence, Risk Factors Tamoxifen-related NAFLD: Prevalence, Incidence, Risk Factors
How common is the development of fatty liver after tamoxifen treatment in breast cancer patients, and what are the associated risk factors?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Universal gut microbiome-derived signature predicts cirrhosis
(University of California - San Diego) UC San Diego School of Medicine researchers report that stool microbiomes of NAFLD patients are distinct enough to potentially be used to accurately predict which persons with NAFLD are at greatest risk for having cirrhosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2020 Category: International Medicine & Public Health Source Type: news

Curb the symptoms of non-alcoholic fatty liver disease by adopting a Mediterranean diet
(Natural News) Multiple studies have found that eating more fish and plant-based foods like fruits, vegetables and whole grains — typical components of the Mediterranean diet — contribute to good health even in old age. According to Harvard Medical School researchers, people who stick to a Mediterranean diet have a 46 percent higher chance of healthy... (Source: NaturalNews.com)
Source: NaturalNews.com - June 26, 2020 Category: Consumer Health News Source Type: news

NAFLD Progression Rates to Cirrhosis, Decompensation, Mortality NAFLD Progression Rates to Cirrhosis, Decompensation, Mortality
This study aimed to elucidate the natural history of NAFLD/NASH by evaluating the impact of liver disease severity and comorbid health conditions on risk of mortality and risk of disease progression.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 22, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Novel antisense drug shows promise in slowing fatty liver disease
(University of California - San Diego) A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2020 Category: International Medicine & Public Health Source Type: news

Risk for Maternal, Neonatal Complications Increased With NAFLD
TUESDAY, June 9, 2020 -- Women with non-alcoholic fatty liver disease (NAFLD) have increased risks for maternal and neonatal complications, according to a study published online June 9 in the Journal of Hepatology. Monika Sarkar, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2020 Category: Pharmaceuticals Source Type: news

Fecal transplants show promise as treatment for non-alcoholic fatty liver disease
(Lawson Health Research Institute) A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease (NAFLD). The randomized controlled trial published in The American Journal of Gastroenterology found that fecal transplants in patients with NAFLD result in a reduction in how easily pathogens and other unwanted molecules pass through the human gut and into circulation, known as intestinal permeability. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2020 Category: International Medicine & Public Health Source Type: news

Mediterranean diet found to ameliorate symptoms of nonalcoholic fatty liver disease
In this study, Greek researchers investigated the effects of the Mediterranean diet (MedDiet) on the clinical, biochemical and inflammatory profile of patients with simple liver steatosis. Their results were published in the Journal of Medicinal Food. Diet is a modifiable key factor and target for the prevention or management of non-alcoholic fatty liver disease (NAFLD).... (Source: NaturalNews.com)
Source: NaturalNews.com - June 2, 2020 Category: Consumer Health News Source Type: news

Modified Parkinson's drug shows potential in treating nonalcoholic fatty liver disease
(GIST(Gwangju Institute of Science and Technology)) Nonalcoholic fatty liver disease (NAFLD) severely impairs the quality of life in patients and often leads to various liver complications. Recently, scientists at Gwangju Institute of Science and Technology designed a novel compound that can potentially treat NAFLD by targeting peripheral serotonin, which regulates lipid metabolism in the liver. They achieved this by structurally modifying an existing neurological drug such that it targets peripheral serotonin by minimizing brain penetration. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 28, 2020 Category: Biology Source Type: news

More Severe COVID-19 in Patients With Liver Fibrosis More Severe COVID-19 in Patients With Liver Fibrosis
Patients with non-alcoholic fatty liver disease (NAFLD) and increased liver-fibrosis scores experience more severe illness from COVID-19, according to a study of Chinese patients.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 26, 2020 Category: Intensive Care Tags: Gastroenterology News Source Type: news

High Rate of Fatty Liver Disease Found in 9/11 Responders High Rate of Fatty Liver Disease Found in 9/11 Responders
The risk for nonalcoholic fatty liver disease appears to be elevated in 9/11 first responders in New York City, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Navigating nonalcoholic fatty liver disease (NAFLD)
(American Gastroenterological Association) Gastroenterology, the official journal of the American Gastroenterological Association (AGA), has released a special issue providing clinicians and researchers an up-to-date resource on the risk factors, natural history, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2020 Category: International Medicine & Public Health Source Type: news

BioIVT introduces high-purity Kupffer cells to support drug discovery and development for liver diseases and help predict adverse drug reactions
(Rana Healthcare Solutions LLC) BioIVT is adding high-purity Kupffer cells to its portfolio of human primary hepatic cells to support drug discovery and development for liver diseases and help predict adverse drug reactions. Kupffer cells perform a scavenger role in the liver, removing small particles, senescent cells and cell debris. They also play an important role in the immune response to liver pathogens. Dysregulation of this response contributes to liver diseases such as NAFLD, NASH, and liver fibrosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news

High Clinical Burden Associated With Nonalcoholic Fatty Liver Disease
WEDNESDAY, May 6, 2020 -- The clinical burden associated with nonalcoholic fatty liver disease (NAFLD) is high, according to a study published online May 5 in Alimentary Pharmacology and Therapeutics. Rohit Loomba, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2020 Category: Pharmaceuticals Source Type: news

Light-to-Moderate Alcohol Consumption Tied to Increased Type 2 Diabetes Risk With NAFLD Light-to-Moderate Alcohol Consumption Tied to Increased Type 2 Diabetes Risk With NAFLD
People with nonalcoholic fatty liver disease are at increased risk of developing type 2 diabetes when they consume light-to-moderate amounts of alcohol than when they abstain from drinking, a Chinese study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Diet Quality and Its Association With NAFLD and Mortality Diet Quality and Its Association With NAFLD and Mortality
This study investigated the impact of diet on non-alcoholic fatty liver disease. Can a high quality diet lower risk of cancer-related and all-cause mortality?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 29, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Liver Stiffness Measurement, Survival, Complications in NAFLD Liver Stiffness Measurement, Survival, Complications in NAFLD
How accurate is liver stiffness measurement for predicting overall survival and liver, cardiovascular and oncologic complications in NAFLD?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 16, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Sugar, Fat, Alcohol … What’s Worse for the Liver?
This webinar will investigate the increasing mortality rates of liver disease in the UK associated with obesity and the excess consumption of alcohol. It will give an overview of non-alcoholic fatty liver disease (NAFLD), which is now the most common  of liver disease affecting an estimated 25-30% of adults and 10% of children in the UK and worldwide. Both NAFLD and alcohol-related fatty liver can progress to severe liver disease including fibrosis, cirrhosis and hepatocellular carcinoma. The roles of genetics, obesity and dietary patterns i n the development and progression of liver disease will be dis...
Source: The Nutrition Society - April 9, 2020 Category: Nutrition Authors: Jade Mitchell Source Type: news

Advanced Fibrosis and Incident CVD in Patients With NAFLD Advanced Fibrosis and Incident CVD in Patients With NAFLD
This study aimed to determine the factors associated with incident cardiovascular events in patients with NAFLD.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 8, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Potential early biomarker to track development of non-alcoholic fatty liver disease
(Joslin Diabetes Center) Research from Rohit N. Kulkarni's lab at Joslin Diabetes Center has uncovered a biomarker in humans tied to the development of Non-Alcoholic Fatty Liver Disease that might help doctors detect early stages of the disease. The researchers also determined that this biomarker, a protein known as 'neuronal regeneration related protein' (or NREP), plays a significant role in the regulation of a pathway that is currently being reviewed in clinical trials as a treatment option for the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2020 Category: International Medicine & Public Health Source Type: news

PCOS Is Associated With NASH Severity and Advanced Fibrosis PCOS Is Associated With NASH Severity and Advanced Fibrosis
Does polycystic ovary syndrome influence severity of non-alcoholic fatty liver disease and risk of advanced fibrosis?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

AI unlocks screening potential of body CT exams
Artificial intelligence (AI)-based assessment of body composition biomarkers...Read more on AuntMinnie.comRelated Reading: From lab to clinic: How AI can help AI enables screening of fracture risk from CT scans AI spots heart disease on CT lung screening exams AI accurately detects vertebral fractures on CT Can AI screen for nonalcoholic fatty liver disease? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 6, 2020 Category: Radiology Source Type: news